"Amobarbital" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
| Descriptor ID |
D000654
|
| MeSH Number(s) |
D03.383.742.698.253.077
|
| Concept/Terms |
Amobarbital Sodium- Amobarbital Sodium
- Sodium, Amobarbital
- Sodium Amobarbital
- Amobarbital, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Amobarbital".
Below are MeSH descriptors whose meaning is more specific than "Amobarbital".
This graph shows the total number of publications written about "Amobarbital" by people in this website by year, and whether "Amobarbital" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 0 | 2 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 3 | 4 |
| 2004 | 0 | 3 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 2 | 6 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 3 | 4 |
| 2010 | 2 | 2 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Amobarbital" by people in Profiles.
-
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease. Molecules. 2020 Nov 06; 25(21).
-
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest. 2021 Apr; 44(4):873-875.
-
Diagnostic accuracy of functional magnetic resonance imaging, Wada test, magnetoencephalography, and functional transcranial Doppler sonography for memory and language outcome after epilepsy surgery: A systematic review. Epilepsia. 2018 12; 59(12):2305-2317.
-
[Attempted suicide with barbiturates purchased online]. Ned Tijdschr Geneeskd. 2016; 160:D491.
-
Propofol as a substitute for amobarbital in Wada testing. J Clin Neurosci. 2015 Nov; 22(11):1830-2.
-
Language dominance in children with epilepsy: concordance of fMRI with intracarotid amytal testing and cortical stimulation. Epilepsy Behav. 2013 Oct; 29(1):7-12.
-
Determination of hemispheric language dominance in the surgical epilepsy patient: diagnostic properties of functional magnetic resonance imaging. Neurologist. 2012 Sep; 18(5):329-31.
-
A comparison of propofol and amobarbital for use in the Wada test. Seizure. 2012 Jun; 21(5):399-401.
-
Utility of pharmacologic provocative neurological testing before embolization of occipital lobe arteriovenous malformations. World Neurosurg. 2011 Sep-Oct; 76(3-4):276-81.
-
Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients? World Neurosurg. 2011 Mar-Apr; 75(3-4):428-30.